Vitrolife AB Cash Flow Conversion Efficiency

Latest as of June 2026: 0.017x

Vitrolife AB cash flow conversion efficiency. Based on the latest financial reports, Vitrolife AB (VITR) has a cash flow conversion efficiency ratio of 0.017x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr140.00 Million ≈ $15.07 Million USD) by net assets (Skr8.13 Billion ≈ $875.35 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Vitrolife AB (2002–2025)

Cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. This chart illustrates how Vitrolife AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Vitrolife AB share price for real-time trading data and today's change.

Vitrolife AB Cash Flow Conversion Ratio Explained

Vitrolife AB cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Vitrolife AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Vitrolife AB ranked by their cash flow conversion efficiency. Also see Vitrolife AB market cap and net worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
RAPT Therapeutics Inc NASDAQ:RAPT	-0.082x
Bank of Chongqing Co Ltd F:CQN	-0.075x
Kemper Corporation NYSE:KMPR	-0.012x
Grupo Aval Acciones y Valores S.A F:6GAA	0.010x
Sanhe Tongfei Refrigeration Co. Ltd. SHE:300990	0.029x
Greentown China Holdings Limited F:G7C	0.081x
Sila Realty Trust, Inc. NYSE:SILA	0.022x
PG Electroplast Limited NSE:PGEL	-0.050x

Annual Cash Flow Conversion Efficiency for Vitrolife AB (2002–2025)

The table below shows the annual cash flow conversion efficiency of Vitrolife AB from 2002 to 2025. Review free cash flow generation of Vitrolife AB to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr7.89 Billion ≈ $849.63 Million	Skr635.00 Million ≈ $68.34 Million	0.080x	+20.97%
2024-12-31	Skr13.64 Billion ≈ $1.47 Billion	Skr907.00 Million ≈ $97.61 Million	0.066x	+11.75%
2023-12-31	Skr12.72 Billion ≈ $1.37 Billion	Skr757.00 Million ≈ $81.47 Million	0.059x	+56.60%
2022-12-31	Skr16.74 Billion ≈ $1.80 Billion	Skr636.00 Million ≈ $68.44 Million	0.038x	+51.66%
2021-12-31	Skr15.34 Billion ≈ $1.65 Billion	Skr384.31 Million ≈ $41.36 Million	0.025x	-85.82%
2020-12-31	Skr2.02 Billion ≈ $217.06 Million	Skr356.45 Million ≈ $38.36 Million	0.177x	-23.14%
2019-12-31	Skr1.80 Billion ≈ $193.45 Million	Skr413.33 Million ≈ $44.48 Million	0.230x	-1.55%
2018-12-31	Skr1.50 Billion ≈ $161.02 Million	Skr349.44 Million ≈ $37.60 Million	0.234x	-8.09%
2017-12-31	Skr1.23 Billion ≈ $132.22 Million	Skr312.19 Million ≈ $33.60 Million	0.254x	+43.04%
2016-12-31	Skr1.02 Billion ≈ $109.81 Million	Skr181.26 Million ≈ $19.51 Million	0.178x	-22.44%
2015-12-31	Skr844.97 Million ≈ $90.93 Million	Skr193.53 Million ≈ $20.83 Million	0.229x	+10.47%
2014-12-31	Skr702.57 Million ≈ $75.61 Million	Skr145.67 Million ≈ $15.68 Million	0.207x	-36.98%
2013-12-31	Skr322.60 Million ≈ $34.72 Million	Skr106.13 Million ≈ $11.42 Million	0.329x	+53.14%
2012-12-31	Skr278.98 Million ≈ $30.02 Million	Skr59.93 Million ≈ $6.45 Million	0.215x	+87.22%
2011-12-31	Skr343.90 Million ≈ $37.01 Million	Skr39.46 Million ≈ $4.25 Million	0.115x	-22.63%
2010-12-31	Skr326.33 Million ≈ $35.12 Million	Skr48.40 Million ≈ $5.21 Million	0.148x	+11.59%
2009-12-31	Skr312.07 Million ≈ $33.58 Million	Skr41.48 Million ≈ $4.46 Million	0.133x	-9.19%
2008-12-31	Skr292.39 Million ≈ $31.47 Million	Skr42.79 Million ≈ $4.61 Million	0.146x	+74.23%
2007-12-31	Skr253.38 Million ≈ $27.27 Million	Skr21.29 Million ≈ $2.29 Million	0.084x	-22.07%
2006-12-31	Skr220.64 Million ≈ $23.74 Million	Skr23.78 Million ≈ $2.56 Million	0.108x	+34.70%
2005-12-31	Skr176.45 Million ≈ $18.99 Million	Skr14.12 Million ≈ $1.52 Million	0.080x	-13.96%
2004-12-31	Skr150.57 Million ≈ $16.20 Million	Skr14.01 Million ≈ $1.51 Million	0.093x	-57.25%
2003-12-31	Skr143.44 Million ≈ $15.44 Million	Skr31.20 Million ≈ $3.36 Million	0.218x	-30.30%
2002-12-31	Skr111.40 Million ≈ $11.99 Million	Skr34.77 Million ≈ $3.74 Million	0.312x	--

About Vitrolife AB

ST:VITR Sweden Medical Devices

Market Cap

$1.68 Billion

Skr15.60 Billion SEK

Market Cap Rank

#6521 Global

#103 in Sweden

Share Price

Skr115.20

Change (1 day)

+0.52%

52-Week Range

Skr85.20 - Skr151.00

All Time High

Skr560.50